5 results
10-K
2020 FY
AUPH
Aurinia Pharmaceuticals Inc
24 Feb 21
Annual report
4:09pm
limitations might hinder our ability to recoup our investment in LUPKYNIS.
Our ability to commercialize LUPKYNIS successfully will also depend in part
40FR12B/A
EX-99.42
AUPH
Aurinia Pharmaceuticals Inc
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
the Securities for a lengthy period of time or at a price which would enable the Subscriber to recoup its investment in the Securities;
(jj)
the Subscriber
- Prev
- 1
- Next